Financial Year |
March 31 2023 |
Monetary Funds |
1,874,186,852.08 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
182,534,073.44 |
Accounts Receivable |
3,912,757,053.62 |
Advances to Suppliers |
1,280,185,983.39 |
Other Receivables |
3,195,052,710.87 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
67,124,903.48 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
2,401,292,528.03 |
Other Current Assets |
38,456,164.48 |
Total Current Assets |
48,163,167,815.03 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
735,040,685.61 |
Investment Properties |
9,187,005.66 |
Fixed Assetes |
648,584,679.04 |
Under-construction Projects |
48,634,454.83 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
114,636,746.28 |
R&D expenses |
-- |
Goodwill |
95,328,285.26 |
Long-Term Deferred and Prepaid Expenses |
5,274,323.02 |
Deferred Income Tax Assets |
275,439,106.55 |
Other Non-Current Assets |
13,938,816,437.49 |
Sub-Total of Non-Current Assets |
15,944,935,713.99 |
Total Assets |
64,108,103,529.02 |
Short-Term Loans |
3,771,296,828.33 |
Trading Financial liabilities |
354,240.00 |
Notes Payable |
664,487,623.42 |
Accounts Payable |
13,609,154,289.84 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
1,849,274,595.74 |
Taxes Payable |
1,851,782,351.93 |
Interest Payable |
-- |
Dividend Payable |
88,684,029.01 |
Other payables |
5,119,269,638.72 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,851,712,474.71 |
Other Current Liabilities |
2,590,915,187.02 |
Sub-Total of Current Liabilities |
32,074,815,262.98 |
Long-term Loans |
18,518,518,035.33 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
18,538,293,778.65 |
Total Liabilities |
50,613,109,041.63 |
Paid-In Capital(Or Share Stock) |
1,529,757,955.00 |
Capital Surplus |
4,047,430,822.62 |
Surplus Reserve |
764,878,977.50 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
5,609,914,336.28 |
Minority Stockholder's Interest |
1,122,746,700.40 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,372,247,786.99 |
Owner's Equity(Stockholder's Equity) |
13,494,994,487.39 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
64,108,103,529.02 |